Advances in Diagnosis and Management of Cardiovascular Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".

Deadline for manuscript submissions: 30 April 2025 | Viewed by 616

Special Issue Editors


E-Mail Website
Guest Editor
Electrophysiology Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
Interests: atrial fibrillation ablation; ventricular tachycardia ablation; supraventricular tachycardia ablation; left atrial appendage closure; ICD/PM implantation; cardiac leads extraction
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Clinical Cardiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy
2. School of Medicine and Surgery, University of Milan-Bicocca, 20900 Monza, Italy
Interests: cardiovascular disease; risk stratification; preventive cardiology; hypertension; dyslipidaemias; heart failure management; interventional cardiology; coronary artery disease; arrythmias

Special Issue Information

Dear Colleagues,

Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, impacting individuals across all stages of life. This Special Issue focuses on cardiovascular disease, encompassing prevention, diagnosis, and treatment of various CVD conditions such as coronary artery disease, heart failure, arrhythmias, hypertension, valvular heart disease and cardiomyopathies. This Special Issue also covers the complex interplay between CVD and other chronic conditions like diabetes, renal disease, and metabolic disorders, highlighting the importance of multidisciplinary care. We aim to publish high-quality scientific articles that contribute to reducing the global burden of CVD through innovative research and clinical practice. Submissions addressing novel approaches in diagnosis, risk stratification, and therapeutic interventions, as well as those exploring the role of lifestyle, genetics, and emerging technologies in CVD management, are particularly welcome. We invite original research articles, case studies, case reports, and reviews that explore cardiovascular disease across diverse populations and age groups. By bringing together research from across the cardiovascular spectrum, this Special Issue seeks to advance our understanding of cardiovascular disease and foster improved patient outcomes

Dr. Fabrizio Guarracini
Prof. Dr. Cristina Giannattasio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiovascular disease
  • risk stratification
  • preventive cardiology
  • hypertension
  • dyslipidaemias
  • heart failure management
  • interventional cardiology
  • coronary artery disease
  • arrythmias

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 2007 KiB  
Article
The Possible Role of Rosuvastatin Therapy in HFpEF Patients—A Preliminary Report
by Tomasz Urbanowicz, Ievgen Spasenenko, Marta Banaszkiewicz, Anna Olasińska-Wiśniewska, Aleksandra Krasińska-Płachta, Andrzej Tykarski, Krzysztof J. Filipiak, Zbigniew Krasiński and Beata Krasińska
Diagnostics 2024, 14(22), 2579; https://doi.org/10.3390/diagnostics14222579 - 16 Nov 2024
Viewed by 477
Abstract
Background: An increasing number of heart failure with preserved ejection fraction (HFpEF) syndromes has been reported in tandem with increasing age and burdens of obesity and cardiometabolic disorders. Identifying possible risk and modulatory HFpEF factors has significant epidemiological and clinical value. This study [...] Read more.
Background: An increasing number of heart failure with preserved ejection fraction (HFpEF) syndromes has been reported in tandem with increasing age and burdens of obesity and cardiometabolic disorders. Identifying possible risk and modulatory HFpEF factors has significant epidemiological and clinical value. This study aimed to assess the prevalence of echocardiographic diagnostic criteria of left ventricular dysfunction in patients with chronic coronary syndrome depending on rosuvastatin therapy. Method: There were 81 (33 (41%) male) consecutive patients with a median age of 70 (62–75) years, presenting with stable heart failure symptoms according to the New York Heart Association (NYHA) classification I to III. They presented with chronic coronary syndrome and were hospitalized between March and August 2024. Patients were divided according to the type of long-term lipid-lowering therapy into patients with rosuvastatin and with other statin therapy. The echocardiographic analysis based on diastolic dysfunction evaluation was performed on admission and compared with demographical, clinical, and laboratory results. Results: In the multivariable model for diastolic dysfunction prediction in the analyzed group based on three echocardiographic parameters, septal E’ below 7 cm/s, lateral E’ below 10 cm/s, and LAVI above 34 mL/m2, the following factors were found to be significant: sex (male) (OR: 0.19, 95% CI: 0.04–0.83, p = 0.027), obesity (defined as BMI > 30) (OR: 12.78, 95% CI: 2.19–74.50, p = 0.005), and rosuvastatin therapy (OR: 0.09, 95% CI: 0.02–0.51, p = 0.007). Conclusions: Rosuvastatin therapy can be regarded as a possible protective therapy against left ventricular diastolic dysfunction in chronic coronary syndrome. Full article
(This article belongs to the Special Issue Advances in Diagnosis and Management of Cardiovascular Diseases)
Show Figures

Figure 1

Back to TopTop